miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.

FEBS Lett

The Molecular Pathology Research Group, Department of Pharmacology, German University in Cairo, Main Entrance Al Tagamoa Al Khames, 11835 Cairo, Egypt. Electronic address:

Published: August 2015

This study aimed to identify a single miRNA or miR (microRNA) which regulates the three insulin-like growth factor-2-mRNA-binding proteins (IGF2BP1, 2 and 3). Bioinformatics predicted miR-1275 to simultaneously target the three IGF2BPs, and screening revealed miR-1275 to be underexpressed in hepatocellular carcinoma (HCC) tissues. Transfection of HuH-7 cells with miR-1275 suppressed IGF2BPs expression and all three IGF2BPs were confirmed as targets of miR-1275. Ectopic expression of miR-1275 and knockdown of IGF2BPs inhibited malignant cell behaviors, and also reduced IGF1R protein and mRNA. Finally IGF1R was validated as a direct target of miR-1275. These findings indicate that the tumor-suppressor miR-1275 can control HCC tumor growth partially through simultaneously regulating the oncogenic IGF2BPs and IGF1R.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2015.06.038DOI Listing

Publication Analysis

Top Keywords

mir-1275
8
tumor growth
8
hepatocellular carcinoma
8
three igf2bps
8
igf2bps
5
mir-1275 single
4
single microrna
4
microrna targets
4
three
4
targets three
4

Similar Publications

Article Synopsis
  • Breast cancer is a complex disease that is very common globally, and while some treatments exist, there's a pressing need to find better drug targets.
  • This study analyzed six sequencing datasets from the GEO database, identifying 67 miRNAs and 133 genes that are differentially expressed in breast cancer, and constructed a miRNA-gene interaction network.
  • Among the identified molecules, three miRNAs were found to significantly impact patient prognosis, leading researchers to propose four potential drug candidates for targeted therapy in breast cancer treatment.
View Article and Find Full Text PDF

The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review.

Biomed Res Int

October 2024

Department of Nutrition, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Curcumin is a polyphenol compound with anticancer effects. We aimed to review the anti-neoplastic effects of curcumin on urogenital cancers, by regulating different microRNA expressions. A systematic search was conducted in Medline (PubMed), Embase, Scopus, and Web of Science up to the end of August 2024.

View Article and Find Full Text PDF

RACK1 inhibits ferroptosis of cervical cancer by enhancing SLC7A11 core-fucosylation.

Glycoconj J

October 2024

Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, 419 Fangxie Road, Shanghai, China.

Receiver for Activated C Kinase 1 (RACK1) is a highly conserved scaffold protein that can assemble multiple kinases and proteins together to form complexes, thereby regulating signal transduction process and various cellular biological processes, including cell cycle regulation, differentiation, and immune response. However, the function and mechanism of RACK1 in cervical cancer remain incompletely understood. Here we identified that RACK1 could significantly suppress cell ferroptosis in cervical cancer cells.

View Article and Find Full Text PDF

Disparities in estrogen receptor (ER), progesterone receptor, human epidermal growth factor receptor 2 (HER2), and Ki67 proliferation indices facilitate the categorization of breast cancer into four principal subtypes: luminal A, luminal B, HER2-positive, and triple-negative breast cancer (TNBC). Preclinical studies investigating the therapeutic potential of histaminergic system targeting in breast cancer have shown promising results. This study aimed to assess the expression profiles of messenger ribonucleic acid (mRNA) and micro RNA (miRNA) related to the histaminergic system in five subtypes of breast cancer among Polish women.

View Article and Find Full Text PDF
Article Synopsis
  • Studies found elevated levels of mitogen-activated protein kinases (MAPKs) in psoriatic lesions, prompting research on their gene expression and regulation in HaCaT keratinocytes under specific treatments.
  • The experiment involved exposing cells to bacterial lipopolysaccharide A (LPS) and adalimumab, using various molecular analysis techniques to evaluate changes in gene expression over time.
  • Results suggested that certain microRNAs (miRNAs) play a role in regulating MAPK expression, indicating they could serve as potential markers for assessing the effectiveness of adalimumab treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!